Published in Neurosurgery on February 01, 2014
Does adjuvant external-beam radiotherapy improve outcomes for nonbenign meningiomas? A Surveillance, Epidemiology, and End Results (SEER)-based analysis. J Neurosurg (2012) 2.29
Phase I/II study of resection and intraoperative cesium-131 radioisotope brachytherapy in patients with newly diagnosed brain metastases. J Neurosurg (2014) 2.03
Intra-arterial delivery of bevacizumab after blood-brain barrier disruption for the treatment of recurrent glioblastoma: progression-free survival and overall survival. World Neurosurg (2011) 1.62
High-viscosity polymethylmethacrylate cement for endoscopic anterior cranial base reconstruction. J Neurosurg (2010) 1.50
Expression of the costimulatory molecule B7-H3 is associated with prolonged survival in human pancreatic cancer. BMC Cancer (2009) 1.12
Activated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cells. J Neurooncol (2009) 1.11
Superselective intraarterial cerebral infusion of bevacizumab: a revival of interventional neuro-oncology for malignant glioma. J Exp Ther Oncol (2009) 1.10
Neural stem cell biology may be well suited for improving brain tumor therapies. Cancer J (2003) 1.05
Glioblastoma stem cells are regulated by interleukin-8 signaling in a tumoral perivascular niche. Cancer Res (2013) 1.03
Zero-profile Anchored Spacer Reduces Rate of Dysphagia Compared With ACDF With Anterior Plating. J Spinal Disord Tech (2015) 1.01
Results and risk factors for recurrence following single-level tubular lumbar microdiscectomy. J Neurosurg Spine (2010) 0.99
Endoscopic endonasal transsphenoidal surgery for functional pituitary adenomas. Neurosurg Focus (2011) 0.96
New strategy for the analysis of phenotypic marker antigens in brain tumor-derived neurospheres in mice and humans. Neurosurg Focus (2008) 0.95
Superselective intra-arterial cerebral infusion of novel agents after blood-brain disruption for the treatment of recurrent glioblastoma multiforme: a technical case series. Neurosurg Clin N Am (2012) 0.94
Long-term expansion of adult human brain subventricular zone precursors. Neurosurgery (2008) 0.92
Glioblastoma stem-like cells-biology and therapeutic implications. Cancers (Basel) (2011) 0.91
The duality of epidermal growth factor receptor (EGFR) signaling and neural stem cell phenotype: cell enhancer or cell transformer? Curr Stem Cell Res Ther (2006) 0.91
Understanding the role of tumor stem cells in glioblastoma multiforme: a review article. J Neurooncol (2010) 0.89
Protein phosphatase 2A mediates dormancy of glioblastoma multiforme-derived tumor stem-like cells during hypoxia. PLoS One (2012) 0.86
Optimization of glioblastoma multiforme stem cell isolation, transfection, and transduction. J Neurooncol (2011) 0.86
Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism. J Lipid Res (2007) 0.86
Phase I/II study of oral erlotinib for treatment of relapsed/refractory glioblastoma multiforme and anaplastic astrocytoma. J Exp Ther Oncol (2012) 0.85
EGFR signaling is differentially activated in patient-derived glioblastoma stem cells. J Exp Ther Oncol (2010) 0.85
Sex, Age, Anatomic Location, and Extent of Resection Influence Outcomes in Children With High-grade Glioma. Neurosurgery (2015) 0.85
The contribution of Notch signaling to glioblastoma via activation of cancer stem cell self-renewal: the role of the endothelial network. Neurosurgery (2012) 0.84
Subtype-specific MEK-PI3 kinase feedback as a therapeutic target in pancreatic adenocarcinoma. Mol Cancer Ther (2013) 0.83
Use of human neural tissue for the generation of progenitors. Neurosurgery (2008) 0.81
Assessing neural stem cell motility using an agarose gel-based microfluidic device. J Vis Exp (2008) 0.80
Tight regulation between cell survival and programmed cell death in GBM stem-like cells by EGFR/GSK3b/PP2A signaling. J Neurooncol (2014) 0.80
Direct conversion of human fibroblasts to functional neurons in one step. Neurosurgery (2011) 0.79
Orthotopic glioblastoma stem-like cell xenograft model in mice to evaluate intra-arterial delivery of bevacizumab: from bedside to bench. J Clin Neurosci (2012) 0.79
Neural stem cells and glioma stem-like cells respond differently to chemotherapeutic drugs: selectivity at the cellular level. Neurosurgery (2011) 0.79
The role of dose escalation with intracavitary brachytherapy in the treatment of localized CNS malignancies: outcomes and toxicities of a prospective study. Brachytherapy (2009) 0.79
Effects of CETP inhibition on triglyceride-rich lipoprotein composition and apoB-48 metabolism. J Lipid Res (2012) 0.79
Therapeutic stem cells encapsulated in a synthetic extracellular matrix selectively kill tumor cells, delay tumor growth, and increase survival in a mouse resection model of malignant glioma. Neurosurgery (2012) 0.77
Industry progress report on neuro-oncology: Biotech update 2013. J Neurooncol (2013) 0.77
Impact of mifepristone, a glucocorticoid/progesterone antagonist, on HDL cholesterol, HDL particle concentration, and HDL function. J Clin Endocrinol Metab (2012) 0.77
Notch inhibition via micro-RNA blocks glioma development. Neurosurgery (2012) 0.77
Disease-specific induced pluripotent stem cells. Neurosurgery (2008) 0.77
Pineal parenchymal tumor of intermediate differentiation with papillary features: a continuum of primary pineal tumors? J Neurooncol (2010) 0.76
Feasibility and safety of GliaSite brachytherapy in treatment of CNS tumors following neurosurgical resection. J Cancer Res Ther (2010) 0.76
Prophylactic plastic surgery closure of neurosurgical scalp incisions reduces the incidence of wound complications in previously-operated patients treated with bevacizumab (Avastin®) and radiation. J Neurooncol (2014) 0.76
Dissecting the perivascular stem-cell niche: can we take tumor recurrence down a NOTCH? Neurosurgery (2012) 0.76
Targeting a heterogeneous tumor: the promise of the interleukin-13 receptor α2. Neurosurgery (2014) 0.75
Magnetic Resonance Imaging to Identify Glioblastoma Molecular Phenotypes. Neurosurgery (2016) 0.75
Gross Total Resection of Glioblastoma Improves Overall Survival and Progression-Free Survival Compared to Subtotal Resection or Biopsy Alone. Neurosurgery (2016) 0.75
A New Tool in Defining Disease Progression in Glioblastoma. Neurosurgery (2015) 0.75
EGFR targeted inhibition resistance: compensatory activation of ERBB family members in glioblastoma cancer stem-like cells promotes proliferation. Neurosurgery (2012) 0.75
Toxin-secreting implantable therapeutic stem cells. Neurosurgery (2015) 0.75
Intra-arterial bevacizumab with blood brain barrier disruption in a glioblastoma xenograft model. J Exp Ther Oncol (2012) 0.75
The intersection between genetic engineering and immunotherapy: taking a BiTE out of glioblastoma. Neurosurgery (2013) 0.75
Brain tumor stem cells: will understanding a new paradigm lead to improved therapies? Expert Rev Neurother (2008) 0.75
Repurposing mebendazole for the treatment of medulloblastoma. Neurosurgery (2015) 0.75
Stem cell migration in a novel model to study pediatric brain tumors. Neurosurgery (2008) 0.75
VIGAS and beyond: the impact of HCMV-infection and its treatment in glioblastoma. Neurosurgery (2014) 0.75
The FIRST Trial: Implications for Neurosurgery. Neurosurgery (2016) 0.75
Forcing tumor stem cells to an end. Neurosurgery (2010) 0.75
Industry progress report on neuro-oncology: a biotech update. J Neurooncol (2013) 0.75
Transdifferentiation-Induced Neural Stem Cells for the Treatment of Malignant Gliomas. Neurosurgery (2016) 0.75
Novel hydrogel application in minimally invasive surgical approaches to spontaneous intracranial hypotension. Report of 2 cases. J Neurosurg (2014) 0.75
Interstitial infusion of erlotinib in the rodent brain. J Exp Ther Oncol (2009) 0.75
The only way out is in: a deeper understanding of anti-VEGF therapy escape mechanisms offers possibilities for more effective antiangiogenic treatment. Neurosurgery (2013) 0.75
Getting a neural stem cell from a fibroblast. Neurosurgery (2012) 0.75
Expanding the borders: the evolution of neurosurgical approaches. Neurosurg Focus (2014) 0.75
Stem cell populated implanted trachea. Neurosurgery (2009) 0.75
Conservative management of cavernous sinus cavernous hemangioma in pregnancy. J Neurosurg (2014) 0.75
Trials and tribulations of cancer immunotherapy: the dendritic cell vaccine shows promise in a phase I glioblastoma multiforme trial. Neurosurgery (2012) 0.75
Radiation Exposure and Safety Precautions Following 131Cs Brachytherapy in Patients with Brain Tumors. Health Phys (2017) 0.75
Cost analysis of intra-arterial versus intra-venous delivery of bevacizumab for the treatment of recurrent glioblastoma multiforme. J Exp Ther Oncol (2011) 0.75
Resetting the stem cell clock: impact of the systemic milieu on oligodendrocyte precursor cell differentiation and remyelination. Neurosurgery (2012) 0.75
Neural stem cells: targeting glioma in 3-dimensions. Neurosurgery (2010) 0.75
Transdifferentiation Induced Neural Stem Cells for the Treatment of Malignant Gliomas. Neurosurgery (2016) 0.75
Stem cell based growth factory delivery to the injured spinal cord. Neurosurgery (2010) 0.75